Listed · Meds Apotek has been listed on First North since September 23, 2025 and is no longer traded through Accumeo.
About the listing
Meds Apotek stock
Meds Apotek was founded in 2018 by Adham, Joanna and Björn, three entrepreneurs with extensive experience in the pharmacy industry and e-commerce. Headquartered in Stockholm, Meds is a full-scale digital pharmacy that sells prescription and over-the-counter medicines authorised by the Swedish Medical Products Agency. Meds has no physical stores but focuses on delivering products directly to customers as quickly as possible.
Other companies you may be interested in
-400x300.png&w=3840&q=75)
-400x300.png&w=3840&q=75)
Note: Share price is from each company's latest known share issue. The change compares it with the previous issue and does not account for splits or differing share classes.
Meds Apotek new issues and valuations
| Date | Type | Share price | Valuation The company's valuation after the funding round was completed (Post-money). | Amount The specific amount raised in this funding round. |
|---|---|---|---|---|
| Q2 2023 | Share issuance | 44 SEK | SEK 759,100,000 | Locked |
| Q2 2022 | Share issuance | 80 SEK | SEK 1,262,300,000 | Locked |
| Q1 2021 | Share issuance | 48.6 SEK | SEK 763,000,000 | Locked |
See the amount raised in every funding round
Free · about two minutes
Note: Information on Meds Apotek's funding rounds, amounts, and valuation is sourced from news media and public sources unless otherwise stated. Information on capital structure is sourced from public company registers unless otherwise stated.
Meds Apotek was founded in 2018 by Adham, Joanna and Björn, three entrepreneurs with extensive experience in the pharmacy industry and e-commerce. Headquartered in Stockholm, Meds is a full-scale digital pharmacy that sells prescription and over-the-counter medicines authorised by the Swedish Medical Products Agency. Meds has no physical stores but focuses on delivering products directly to customers as quickly as possible.
Note: Information on Meds Apotek is sourced from official channels and public sources unless otherwise stated.
Major Shareholders in Meds Apotek
| Owner | Share |
|---|---|
| M2 Asset Management AB | 14.57 % |
| Coeli Wealth Management AB | 9.91 % |
| Ilija Batljan Invest AB | 5.26 % |
| Bjorn Thorngren | 4.02 % |
| CNI Nordic 5 AB | 4.00 % |
Source: Eivora (9/5/2025) · Information on Meds Apotek's ownership structure is sourced from public company registers and external data providers unless otherwise stated.
Meds Apotek key figures
No key figures available.
News about Meds Apotek
Meds tecknar nytt logistikavtal
Meds Apotek kommer att flytta in i en ny logistikfastighet i Eskilstuna i augusti, vilket tredubblar deras lagerstorlek. Arena Personal kommer att sköta driften och bemanningen av det nya logistikcentrumet.
Han lovar en miljon kronor – till den som vill ta över Meds gamla lager
Nätapoteket Meds utlovar en miljon kronor i hittelön till den som kan ta över deras gamla lagerlokaler efter flytten till nya, större utrymmen.
Meds Apotek vill fortsätta växa snabbare än marknaden - vd
Meds makes its stock market debut – this is how the first day went
Tuesday marked the stock market debut of online pharmacy Meds. The share price got off to a flying start when trading began, but then slowed down somewhat.
Meds Apotek Shares Surge 23 Percent in First North Debut
The pharmacy company Meds Apotek saw its shares soar in their debut trading session on First North this Tuesday.
FAQ
Yes. Meds Apotek has been listed on First North since September 23, 2025.
The largest shareholders in Meds Apotek are M2 Asset Management AB (14.57 %), Coeli Wealth Management AB (9.91 %), and Ilija Batljan Invest AB (5.26 %). The figures come from Eivora and were last updated in September 2025.
The CEO of Meds Apotek is Björn Thorngren. The board is chaired by Christian W. Jansson.
Disclaimer: The information in this FAQ is provided for informational purposes only and does not constitute an offer to buy or sell securities, a solicitation of such an offer, or investment advice. Accumeo has no commercial relationship with the companies whose securities are mentioned. Independent advice should be obtained before making any investment decision.
Start exploring unlisted shares today
Join 5,000+ investors already trading unlisted shares. Create an account in 2 minutes with BankID — completely free.